Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management-Reference-Cited by-同舟云学术

Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management

Published:2017-01-11 Issue:4 Volume:101 Page:469-480
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Mosedale M¹,Watkins PB¹

Affiliation:

1. Institute for Drug Safety Sciences, University of North Carolina at Chapel Hill, Research Triangle Park, North Carolina, USA; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy; Chapel Hill North Carolina USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases Project

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.564/fullpdf

Reference74 articles.

1. Drug-induced acute liver failure;Lee;Clin Liver Dis.,2013

2. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset;Fontana;Gastroenterology,2014

3. How to diagnose and exclude drug-induced liver injury;Watkins;Dig Dis (Basel).,2015

4. Drug safety sciences and the bottleneck in drug development;Watkins;Clin Pharmacol Ther.,2011

5. http://www.bloomberg.com/news/2013-12-27/takeda-scraps-development-of-diabetes-drug-on-risks-shares-drop.html Takeda Shares Drop After Scrapping Development of Diabetes Drug 2013

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut–Liver Axis as a Therapeutic Target for Drug-Induced Liver Injury;Current Issues in Molecular Biology;2024-02-01

2. Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction;Cellular and Molecular Life Sciences;2024-01-12

3. Single cell omics in tracing cellular heterogeneity of drug-induced liver injury: technological landscape and prospective application;hLife;2024-01

4. Quantitative Systems Toxicology Modeling Informed Safe Dose Selection of Emvododstat in Acute Myeloid Leukemia Patients;Clinical Pharmacology & Therapeutics;2023-12-21

5. DRUG-INDUCED LIVER INJURY: MECHANISMS, METHODS FOR PRE-CLINICAL ASSESSMENT, AND A MEDICINAL CHEMIST’S PERSPECTIVE;Medicinal Chemistry Reviews;2023-11-16